Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern Iran

Authors Information
Article Notes and Dates
To Cite : Kargar Kheirabad A, Bahri F, Kargar M, Ghasemzadeh I. Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern Iran, Hepat Mon. 2016 ;16(10):e40375. doi: 10.5812/hepatmon.40375.
Copyright: Copyright © 2016, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Ramia S, Koussa S, Taher A, Haraki S, Klayme S, Sarkis D, et al. Hepatitis-C-virus genotypes and hepatitis-G-virus infection in Lebanese thalassaemics. Ann Trop Med Parasitol. 2002; 96(2): 197-202[DOI][PubMed]
  • 2. MacDonald M, Crofts N, Kaldor J. Transmission of hepatitis C virus: rates, routes, and cofactors. Epidemiol Rev. 1996; 18(2): 137-48[PubMed]
  • 3. Taherkhani R, Farshadpour F. Epidemiology of hepatitis C virus in Iran. World J Gastroenterol. 2015; 21(38): 10790-810[DOI][PubMed]
  • 4. Smith DB, Cuceanu N, Davidson F, Jarvis LM, Mokili JL, Hamid S, et al. Discrimination of hepatitis G virus/GBV-C geographical variants by analysis of the 5' non-coding region. J Gen Virol. 1997; 78 ( Pt 7): 1533-42[DOI][PubMed]
  • 5. Abdulkarim AS, Zein NN, Germer JJ, Kolbert CP, Kabbani L, Krajnik KL, et al. Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis C virus subtypes. Am J Trop Med Hyg. 1998; 59(4): 571-6[PubMed]
  • 6. Alavian SM, Ahmadzad-Asl M, Lankarani K, Shahbabaie M, Bahrami Ahmadi A, Kabir A. Hepatitis C infection in the general population of Iran: A systematic review. Hepat Mon. 2009; 9(3): 211-23
  • 7. Schwarze-Zander C, Blackard JT, Zheng H, Addo MM, Lin W, Robbins GK, et al. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. J Infect Dis. 2006; 194(4): 410-9[DOI][PubMed]
  • 8. Kafi-Abad S, Samiei S, Talebian A, Maghsudloo M, Gharehbaghian A. Hepatitis G virus infection in Iranian blood donors and high-risk groups. Hepat Mon. 2009; 9(4): 282-6
  • 9. Eslamifar A, Hamkar R, Ramezani A, Ahmadi F, Gachkar L, Jalilvand S, et al. Hepatitis G virus exposure in dialysis patients. Int Urol Nephrol. 2007; 39(4): 1257-63[DOI][PubMed]
  • 10. Giret MT, Miraglia JL, Sucupira MC, Nishiya A, Levi JE, Diaz RS, et al. Prevalence, incidence density, and genotype distribution of GB virus C infection in a cohort of recently HIV-1-infected subjects in Sao Paulo, Brazil. PLoS One. 2011; 6(4): 18407[DOI][PubMed]
  • 11. Bahri F, Kargar Kheirabad A, Ghasemzadeh I, Shoja S, Gouklani H. Hepatitis Viruses B and D and Human Immunodeficiency Virus Infections in Hemodialysis Patients in the South of Iran: Prevalence and Genotypes. Hepat Mon. 2016; 16(1): 32971[DOI][PubMed]
  • 12. Alavian SM, Kabir A, Ahmadi AB, Lankarani KB, Shahbabaie MA, Ahmadzad-Asl M. Hepatitis C infection in hemodialysis patients in Iran: a systematic review. Hemodial Int. 2010; 14(3): 253-62[DOI][PubMed]
  • 13. Yang JF, Dai CY, Chuang WL, Lin WY, Lin ZY, Chen SC, et al. Prevalence and clinical significance of HGV/GBV-C infection in patients with chronic hepatitis B or C. Jpn J Infect Dis. 2006; 59(1): 25-30[PubMed]
  • 14. Hofer H, Aydin I, Neumueller-Guber S, Mueller C, Scherzer TM, Staufer K, et al. Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy. J Viral Hepat. 2011; 18(7): 513-7[DOI][PubMed]
  • 15. Samadi M, Keyvani H, Moghaddam SMH. Prevalence and risk factors of the hepatitis G (HGV) infection in hemodialysis patients. Arch Clin Infect Dis. 2008; 3(1)
  • 16. Fallahian F, Alavian SM, Rasoulinejad M. Epidemiology and transmission of hepatitis G virus infection in dialysis patients. Saudi J Kidney Dis Transpl. 2010; 21(5): 831-4[PubMed]
  • 17. Xia X, Luo J, Bai J, Yu R. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health. 2008; 122(10): 990-1003[DOI][PubMed]
  • 18. Su Y, Norris JL, Zang C, Peng Z, Wang N. Incidence of hepatitis C virus infection in patients on hemodialysis: a systematic review and meta-analysis. Hemodial Int. 2013; 17(4): 532-41[DOI][PubMed]
  • 19. Makkar V, Gupta D, Bansal K, Khaira NS. Prevalence, seroconversion and risk factors of hepatitis b and c infection in patients on maintenance hemodialysis. JEMDS. 2014; 3(11790-7): 50
  • 20. Hassanshahi G, Arababadi MK, Assar S, Hakimi H, Karimabad MN, Abedinzadeh M, et al. Post-transfusion-transmitted hepatitis C virus infection: a study on thalassemia and hemodialysis patients in southeastern Iran. Arch Virol. 2011; 156(7): 1111-5[DOI][PubMed]
  • 21. Mousavi SF, Moosavy SH, Alavian SM, Eghbali H, Mahboobi H. Distribution of hepatitis C virus genotypes among patients with hepatitis C virus infection in hormozgan, iran. Hepat Mon. 2013; 13(12): 14324[DOI][PubMed]
  • 22. Makiani MJ, Davoodian P, Abedi F, Hossini M, Zare S, Rahimi S, et al. AIDS and hepatitis B and C high risk behaviors among 15 to 45 years old individuals in Bandar Abbas (Iran) in 2012. Electron Physician. 2014; 6(3): 884-9[DOI][PubMed]
  • 23. Hosseini-Moghaddam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, et al. Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran--a multicenter study. J Med Virol. 2006; 78(5): 569-73[DOI][PubMed]
  • 24. Taziki O, Espahbodi F. Prevalence of hepatitis C virus infection in hemodialysis patients. Saudi J Kidney Dis Transpl. 2008; 19(3): 475-8[PubMed]
  • 25. Joukar F, Besharati S, Mirpour H, Mansour-Ghanaei F. Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran: HCV and HBV seroprevalence in hemodialysis patients. Hepat Mon. 2011; 11(3): 178-81[PubMed]
  • 26. Zahedi MJ, Darvish Moghaddam S, Alavian SM, Dalili M. Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran. Hepat Mon. 2012; 12(5): 339-43[DOI][PubMed]
  • 27. Amiri ZM, Shakib AJ, Toorchi M. Seroprevalence of hepatitis C and risk factors in haemodialysis patients in Guilan, Islamic Republic of Iran. East Mediterr Health J. 2005; 11(3): 372-6[PubMed]
  • 28. Huraib SO. Hepatitis C in dialysis patients. Saudi J Kidney Dis Transpl. 2003; 14(4): 442-50[PubMed]
  • 29. Zeldis JB, Depner TA, Kuramoto IK, Gish RG, Holland PV. The prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Intern Med. 1990; 112(12): 958-60[PubMed]
  • 30. Marinaki S, Boletis JN, Sakellariou S, Delladetsima IK. Hepatitis C in hemodialysis patients. World J Hepatol. 2015; 7(3): 548-58[DOI][PubMed]
  • 31. El-Amin HH, Osman EM, Mekki MO, Abdelraheem MB, Ismail MO, Yousif ME, et al. Hepatitis C virus infection in hemodialysis patients in Sudan: two centers' report. Saudi J Kidney Dis Transpl. 2007; 18(1): 101-6[PubMed]
  • 32. Tu AW, Buxton JA, Whitlock M, Djurdjev O, Chong M, Krajden M, et al. Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia: Follow-up after a possible breach in hemodialysis machines. Can J Infect Dis Med Microbiol. 2009; 20(2): 19-23[PubMed]
  • 33. Al-Jamal M, Al-Qudah A, Al-Shishi KF, Al-Sarayreh A, Al-Quraan L. Hepatitis C virus (HCV) infection in hemodialysis patients in the south of Jordan. Saudi J Kidney Dis Transpl. 2009; 20(3): 488-92[PubMed]
  • 34. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014; 61(1 Suppl)-57[DOI][PubMed]
  • 35. Albuquerque AC, Coelho MR, Lopes EP, Lemos MF, Moreira RC. Prevalence and risk factors of hepatitis C virus infection in hemodialysis patients from one center in Recife, Brazil. Mem Inst Oswaldo Cruz. 2005; 100(5): 467-70[PubMed]
  • 36. Bdour S. Hepatitis C virus infection in Jordanian haemodialysis units: serological diagnosis and genotyping. J Med Microbiol. 2002; 51(8): 700-4[DOI][PubMed]
  • 37. Schaefer M, Mauss S. Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects. Curr Drug Abuse Rev. 2008; 1(2): 177-87[PubMed]
  • 38. Dolan KA, Shearer J, White B, Zhou J, Kaldor J, Wodak AD. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Addiction. 2005; 100(6): 820-8[DOI][PubMed]
  • 39. Olmer M, Bouchouareb D, Zandotti C, de Micco P, de Lamballerie X. Transmission of the hepatitis C virus in an hemodialysis unit: evidence for nosocomial infection. Clin Nephrol. 1997; 47(4): 263-70[PubMed]
  • 40. Alfurayh O, Sabeel A, Al Ahdal MN, Almeshari K, Kessie G, Hamid M, et al. Hand contamination with hepatitis C virus in staff looking after hepatitis C-positive hemodialysis patients. Am J Nephrol. 2000; 20(2): 103-6[PubMed]
  • 41. Abedian F, Yavarian M, Shakibzadeh A, Khalvati B, Asadi AH. A pilot Seroepidemiologic study of HTLV in thalassemia, hemophilia, and hemodialysed patients in Hormozgan. HMJ. 2009; 13(2): 75-80
  • 42. Hassan AA, Khalil R. Hepatitis C in dialysis patients in egypt: relationship to dialysis duration, blood transfusion, and liver disease. Saudi J Kidney Dis Transpl. 2000; 11(1): 72-3[PubMed]
  • 43. Rezaee-Zavareh MS, Hadi R, Karimi-Sari H, Hossein Khosravi M, Ajudani R, Dolatimehr F, et al. Occult HCV Infection: The Current State of Knowledge. Iran Red Crescent Med J. 2015; 17(11): 34181[DOI][PubMed]
  • 44. Rezaee-Zavareh MS, Ramezani-Binabaj M, Moayed Alavian S. Screening for occult hepatitis C virus infection: Does it need special attention? Hepatology. 2015; 62(1): 321-2[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check